Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N02 ANALGESICS
N02A OPIOIDS
N02AX Other opioids
N02AX07 Oliceridine
D11214 Oliceridine (USAN/INN) <US>
USP drug classification [BR:br08302]
Analgesics
Opioid Analgesics, Short-acting
Oliceridine
D11214 Oliceridine (USAN/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Opioid
OPRM1
D11214 Oliceridine (USAN/INN) <US>
Not elsewhere classified
Signaling molecules
Signaling adaptor
ARRB
D11214 Oliceridine (USAN/INN) <US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11214
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11214
Pharmacogenomic biomarkers [br08341.html]
Polymorphisms and mutations affecting drug response
D11214
Other DBs
CAS:
1401028-24-7
PubChem:
384585192
KCF data
ATOM 27
1 C8y C 8.4700 -21.2100
2 C1b C 9.6600 -21.9100
3 N1b N 10.8500 -21.2100
4 C1b C 12.0400 -21.9100
5 C1b C 13.2300 -21.2100
6 C1z C 14.4200 -21.9100
7 C1x C 14.4200 -23.3100
8 C1x C 15.6100 -24.0100
9 O2x O 16.8700 -23.3100
10 C1z C 16.8700 -21.9100
11 C1x C 15.6100 -21.2100
12 C8y C 14.4200 -20.5100
13 C8x C 15.6100 -19.8100
14 C8x C 15.6100 -18.4100
15 C8x C 14.4200 -17.7100
16 C8x C 13.2300 -18.4100
17 N5x N 13.2300 -19.8100
18 C1x C 18.7600 -20.5800
19 C1x C 19.1800 -21.9100
20 C1x C 17.9900 -22.7500
21 C1x C 17.3600 -20.5800
22 C8x C 6.6500 -19.8800
23 C8x C 6.2300 -21.2100
24 S2x S 7.3500 -22.0500
25 C8y C 8.0500 -19.8800
26 O2a O 8.8776 -18.7508
27 C1a C 10.2825 -18.7643
BOND 30
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 6 5 1 #Down
6 6 7 1
7 7 8 1
8 8 9 1
9 9 10 1
10 10 11 1
11 6 11 1
12 6 12 1 #Up
13 12 13 2
14 13 14 1
15 14 15 2
16 15 16 1
17 16 17 2
18 12 17 1
19 18 19 1
20 19 20 1
21 20 10 1
22 10 21 1
23 18 21 1
24 22 23 2
25 23 24 1
26 24 1 1
27 1 25 2
28 22 25 1
29 25 26 1
30 26 27 1